Key Market Indicators
By 2026, the prevalence of HIV/AIDS among people aged 0-14 years in Guyana is expected to reach approximately 525 individuals, an increase of 0.6% from 2021. Since 1995, demand for HIV/AIDS treatment in Guyana has grown at an average rate of 0.2% each year. In 2021, Guyana was ranked 83rd in the world, with Paraguay at the top with 506 individuals. Nigeria, Mozambique, and Tanzania took the next three spots, respectively. By 2026, the treatment coverage for people living with HIV in Guyana is projected to reach 80%, a 2.4% increase from 2021. Since 2008, the market for HIV/AIDS treatments in Guyana has grown by 3.5% each year. In 2021, Guyana was ranked 65th globally, with Niger in first place with 69%. The other top countries were Cape Verde, Latvia, and Zimbabwe.
